New research suggests that review of current prostate cancer screening guidelines may be needed, as MRI frequently fails to detect cancer-indicative lesions, even in men with elevated PSA levels.
Strategies to reduce MRI overuse in prostate cancer screening are needed. Magnetic resonance imaging (MRI) has been proposed to enhance prostate cancer screening, but it may be overused.
Strategies to reduce MRI overuse in prostate cancer screening are needed. Magnetic resonance imaging (MRI) has been proposed to enhance prostate cancer screening, but it may be overused.
Combining a new blood test with MRI cuts the societal cost of prostate cancer screening and reduces the overdiagnosis of low-risk cancers, supporting organized prostate cancer testing in Sweden.